Domov › Adenokarcinóm pažeráka › Ohio
Klinické štúdie Adenokarcinóm pažeráka v štáte Ohio
13 štúdií pre Adenokarcinóm pažeráka hľadá účastníkov v zariadeniach v štáte Ohio.
Mestá v štáte Ohio
Oficiálny text štúdie (anglicky)
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
- University of Cincinnati Cancer Center, Cincinnati
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 10. 2026 · NCT07544589Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
- Miami Valley Hospital South, Centerville
- Miami Valley Hospital, Dayton
- Premier Blood and Cancer Center, Dayton
- a 3 ďalších
Prebieha náborFáza 2/3
Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 10. 2026 · NCT06203600Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma
- University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 10. 2026 · NCT06044311mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
- Strecker Cancer Center-Belpre, Belpre
- Miami Valley Hospital South, Centerville
- Adena Regional Medical Center, Chillicothe
- a 30 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05677490A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
- Local Institution - 0443, Cleveland
- Local Institution - 0222, Cleveland
Prebieha náborFáza 2/3
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07221149Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
- Oncology Hematology Care Clinical Trials, LLC, Cincinnati
- Oncology Hematology Care Clinical Trials, LLC, Cincinnati
- Oncology Hematology Care Clinical Trials, LLC, Cincinnati
- a 1 ďalších
Prebieha náborFáza 2/3
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07392892Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
- University Hospitals Cleveland Medical Center, Cleveland
- Cleveland Clinic Taussig Cancer Center, Cleveland
Prebieha náborVítaní zdravých dobrovoľníkov
Vek 50 a viac · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT06687603Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
- Case Western Reserve University, Cleveland
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT06732388Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
- Cleveland VA Medical Research and Education Foundation, Cleveland
- University Hospitals Cleveland Medical Center Case Western University, Cleveland
- Cleveland Clinic Foundation, Cleveland
Prebieha nábor
Vek 18 až 89 · Všetky pohlavia · Aktualizované 11. 9. 2026 · NCT05753748Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- Research Site, Columbus
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT07431281A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Maumee
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 8. 2026 · NCT07182149Obeticholic Acid for Prevention in Barrett's Esophagus
- Case Western Reserve University, Cleveland
- Seidman Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland
- University Hospitals Cleveland Medical Center, Cleveland
- a 1 ďalších
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 11. 8. 2026 · NCT04939051First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
- Research Site, Cleveland
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 12. 6. 2026 · NCT07284186Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.